Small Molecules, Large Biologics and the Biosimilar Debate
From Small Molecules to Large Biologics: a look at the impact of relative size and complexity and how it impacts the biosimilar debate in the states. Many small molecule drugs can be taken orally, and tend to work in the body within cells. Since biologics are significantly larger in size, they are typically injected … Continue reading Small Molecules, Large Biologics and the Biosimilar Debate
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed